Healthcare | Mergers & Acquisitions

Immucor Acquires Gamma Biologicals

  • Immucor, Inc. (NASDAQ: BLUD) is a leading supplier of diagnostic reagents and automated instrumentation to ensure the safety of blood transfusions
  • Immucor retained TM Capital as financial advisor to assist in an acquisition program which would build the company’s position in the transfusion diagnostics marketplace
  • TM Capital assisted Immucor in negotiating the acquisition of Gamma Biologicals, Inc. (AMEX: GBL) for $30 million via a cash tender offer for which TM Capital also served as dealer manager

Client Testimonial